ASH 2021 Conference Coverage on VuMedi


 

ASH 2021: Genomic and Immune Signatures Predict Sustained MRD Negativity in NDMM Patients Treated with D-KRd

166 views
December 16, 2021
Comments 0
Login to view comments. Click here to Login